Direkt zum Inhalt
Merck

Fortfahren mit

V0627

Valinomycin

≥90% (HPLC),≥98% (TLC), K+-selective ionophore , powder

Synonym(e):

[(D-Val-L-Lac-Val-D-HyV)(3)](cycl.) (L-Lac: L-Milchsäure, D-HyV: D-α-Hydroxy-isovaleriansäure)

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
Größe/SKUVerfügbarkeitPreis
10 mg
Warenkorb auf Verfügbarkeit prüfen
€ 143,00
25 mg
Warenkorb auf Verfügbarkeit prüfen
€ 156,00
100 mg
Warenkorb auf Verfügbarkeit prüfen
€ 349,00
500 mg
Warenkorb auf Verfügbarkeit prüfen
€ 1.750,00

Über diesen Artikel

Empirische Formel (Hill-System):
C54H90N6O18
CAS-Nummer:
Molekulargewicht:
1111.32
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
217-896-6
MDL number:
Beilstein/REAXYS Number:
78657
Assay:
≥90% (HPLC), ≥98% (TLC)
Form:
powder
Storage condition:
(Keep container tightly closed in a dry and well-ventilated place.)

€ 143,00


Warenkorb auf Verfügbarkeit prüfen

​
Sonderanfertigung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


Produktname

Valinomycin, ≥98% (TLC), ≥90% (HPLC)

Quality Segment

assay

≥90% (HPLC), ≥98% (TLC)

form

powder

storage condition

(Keep container tightly closed in a dry and well-ventilated place.)

color

white

solubility

DMSO: ≥50 mg/mL, H2O: insoluble

antibiotic activity spectrum

Gram-positive bacteria, parasites, viruses

mode of action

cell membrane | interferes

storage temp.

2-8°C

SMILES string

CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C

InChI

1S/C54H90N6O18/c1-22(2)34-49(67)73-31(19)43(61)55-38(26(9)10)53(71)77-41(29(15)16)47(65)59-36(24(5)6)51(69)75-33(21)45(63)57-39(27(11)12)54(72)78-42(30(17)18)48(66)60-35(23(3)4)50(68)74-32(20)44(62)56-37(25(7)8)52(70)76-40(28(13)14)46(64)58-34/h22-42H,1-21H3,(H,55,61)(H,56,62)(H,57,63)(H,58,64)(H,59,65)(H,60,66)/t31-,32-,33-,34-,35+,36+,37-,38-,39-,40+,41+,42+/m0/s1

InChI key

FCFNRCROJUBPLU-RPUZOQEISA-N

General description

Chemical structure: peptide
Valinomycin is a cyclic peptide, which contains d-valine, d-α-hydroxyvaleric acid, l-valine, and l-lactic acid in the sequential order of cyclo-[(l-Val-d-Hyv-d-Val-l-Lac)3].
Valinomycin, a nonribosomal peptide (NRP), is proposed to have a structure of a 24-membered cyclic peptide cyclo-(d-α-hydroxyisovaleryl-d-valyl-l-lactyl-l-valyl)2. It exhibits antitumor properties and plays a major role as a mitophagy activator. Initially isolated as an antibiotic compound, valinomycin has demonstrated antibacterial activity against Mycobacterium tuberculosis. Moreover, it has been identified as a potent antiviral agent against a wide spectrum of viruses, including human coronavirus, bunyavirus, enterovirus, and flavivirus.

Application

Valinomycin has been used:
  • to equilibrate intracellular pH and extracellular pH of 5 (and 6-)-carboxyfluorescein succinimidyl ester (cFSE) in Escherichia coli strain B23
  • as an ionophore to equilibrate intracellular pH and extracellular pH of lactic acid bacteria (LAB) strains
  • to establish the desired pH for acid-base transition and formation of K+-valinomycin diffusion potential

Biochem/physiol Actions

K+-selective ionophore which uncouples oxidative phosphorylation.
K+-selective ionophoric cyclodepsipeptide; potassium ionophore which uncouples oxidative phosphorylation, induces apoptosis in murine thymocytes, inhibits NGF-induced neuronal differentiation and antagonizes ET-induced vasoconstriction.
Valinomycin selectively transfers alkali metal ions via biological and synthetic membranes. The formation of a metal ion-peptide complex contributes to this ion-transporting. Valinomycin can create stable complexes with potassium, rubidium, and cesium (K+, Rb+, and Cs+) .

Packaging

10MG,25MG,100MG,500MG

Other Notes

Keep container tightly closed in a dry and well-ventilated place.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
9467560403V3639
description

≥98% (TLC), ≥90% (HPLC)

description

≥99.0% (TLC)

description

Selectophore™, function tested

description

Ready Made Solution, ~1 mg/mL in DMSO

form

powder

form

powder

form

powder or crystals

form

liquid, ready-to-use solution

assay

≥90% (HPLC), ≥98% (TLC)

assay

≥99.0% (TLC)

assay

≥90.0% (HPLC)

assay

≥90% (HPLC)

Quality Level

300

Quality Level

200

Quality Level

200

Quality Level

200

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage condition

(Keep container tightly closed in a dry and well-ventilated place.)

storage condition

-

storage condition

(Tightly closed. Dry.)

storage condition

(Keep container tightly closed in a dry and well-ventilated place. Hydroscopic.)

solubility

DMSO: ≥50 mg/mL, H2O: insoluble

solubility

-

solubility

-

solubility

-


Still not finding the right product?

Explore all of our products under Valinomycin


Piktogramme

Skull and crossbones

Signalwort

Danger

Gefahrencodes

Hazard Classifications

Acute Tox. 1 Dermal - Acute Tox. 1 Oral

Lagerklasse

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

Was ist los?

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

PSA (Persönliche Schutzausrüstung)

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen




Questions

Reviews

No rating value

Active Filters